Blood Proteins and Platelets

Blood Proteins and Platelets refers to a broad category of circulatory components rather than a single molecular target. Blood proteins, primarily synthesized in the liver, include albumin, globulins, and fibrinogen, which are vital for maintaining osmotic pressure, transporting ligands, and facilitating the coagulation cascade (StatPearls, 2023). Platelets, or thrombocytes, are small, anucleated cell fragments derived from megakaryocytes that are essential for primary hemostasis and wound healing (NIH, 2022). In a pharmacological context, specific proteins (like Thrombin or Factor Xa) and platelet receptors (like P2Y12 or Glycoprotein IIb/IIIa) serve as high-value therapeutic targets for treating cardiovascular and thromboembolic diseases. Because this term encompasses a wide array of distinct biological entities with diverse functions, it is classified as an aggregate term rather than a specific drug target. Understanding the interactions between drugs and these components is crucial for predicting pharmacokinetics and managing bleeding risks associated with antithrombotic therapy (PubMed, 2021).

Other names

Plasma proteinsThrombocytesCoagulation factors and plateletsHemostatic components

Drugs targeting these components typically act by inhibiting platelet activation and aggregation (e.g., P2Y12 antagonists), inhibiting specific coagulation factors (e.g., Factor Xa or Thrombin inhibitors), or modulating the synthesis of clotting factors (e.g., Vitamin K antagonists).